| Literature DB >> 30023540 |
Miyeon Lee1, Young Ho Park2, Eun Bi Kang3, Ari Chae3, Yujin Choi3, Seongho Jo3, Yu Jin Kim4, Soo-Jin Park5, Byunggak Min3, Tae Kyu An3, Jihoon Lee3, Su-Il In2, Sang Youl Kim1, Sung Young Park3,3, Insik In3,3.
Abstract
The preparation of blue-emitting black phosphorus quantum dots (BPQDs) is based on the liquid-phase exfoliation of bulk BP. We report the synthesis of soluble BPQDs showing a strong visible blue-light emission. Highly fluorescent (photoluminescence quantum yield of ≈5% with the maximum emission (λmax) at ≈437 nm) and dispersible BPQDs in various organic solvents are first prepared by simple ultrasonication of BP crystals in chloroform in the ambient atmosphere. Furthermore, simple mussel-inspired surface functionalization of BPQDs with catechol-grafted poly(ethylene glycol) in basic buffer afforded water-soluble blue-emitting BPQDs showing long-term fluorescence stability, very low cytotoxicity, and excellent fluorescence live cell imaging capability.Entities:
Year: 2017 PMID: 30023540 PMCID: PMC6044902 DOI: 10.1021/acsomega.7b01058
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1(a) UV–vis spectrum of the chloroform dispersion of the BPQDs. (b) PL and PLE spectra of the blue-emitting BPQDs. (c) The luminescence decay profiles of the blue-emitting BPQDs dispersion prepared in chloroform. (d) The PLE and PL spectra showing that the UV emission at 352 nm is maximized at the excitation wavelength of 300 nm. (e) Photo images of the dispersions of blue-emitting BPQDs in various solvents.
Figure 2(a) TEM images of BPQDs. (b) The HRTEM images of BPQDs. (c) The AFM topographic images and sectional view of BPQDs.
Figure 3(a) FTIR spectra of BPs and BPQDs. (b) XPS survey scans of BPs and (c) high-resolution P 2p spectrum of the pristine BPs. (d) High-resolution P 2p spectrum of BPQDs. (e) EDX mapping of the TEM image of the BPQDs.
Figure 4(a) UV–vis absorption spectra of PEG-g-PNIPAM (black line), CA-PEG (red line), and PEG-BPQD (blue line). (b) PL spectra and normalized PL spectra (top-right inset) of the PEG-BPQDs. (c) In vitro cell viability of PEG-BPQD investigated toward either MDCK normal cells or KB tumor cells depending on the concentration of BPQDs. (d) Confocal fluorescence image of KB tumor cells treated with PEG-BPQDs (1 or 10 mg/mL, respectively).